ooppps- meant to add GT1 to subject.
Thanks for the info Katia.......... Nothing short of fantastic results for geno 1 null responders and 12 weeks to boot............
Agree with Can-do. Very hopeful and impressive.
Agree. Very hopeful. Abbott's regimen is 3 drugs (a protease inhibitor, a polymerase inhibitor, and a NS5A inhibitor all developed by ABT). They had their best results when combining these 3 drugs with Ribavirin, and most effective with GT1b's, but also excellent results for GT1a's, both treatment naives and null responders.
All is fantastic
Next question: when are the drugs going to be on the market? What is the best case scenario? 2014? 2015?
There is no way to know. Some are in Phase 2 trials and some are in Phase 3 trials. After trials are completed, the companies have to compile their data and apply for FDA approval, and then wait to receive approval. After that, it takes time for them to market the drugs before they are actually available to doctors to prescribe. It is a long process.
Will this combo be suitable for tripple failures?...